Medical and nonmedical therapies for benign prostatic hypertrophy

Geriatrics. 1991 Jun;46(6):26-31, 34.

Abstract

Benign prostatic hypertrophy (BPH) is a common disorder of elderly men, affecting about 80% of men by the age of 80. Until recently, therapeutic options were limited, and transurethral surgery was the most common remedy. In recent years, however, a number of alternatives to traditional surgery have evolved. This article reviews and evaluates current medical and nonmedical therapies for BPH.

Publication types

  • Review

MeSH terms

  • Aged
  • Androgen Antagonists / pharmacology
  • Androgen Antagonists / therapeutic use
  • Catheterization / psychology
  • Catheterization / standards
  • Catheterization / statistics & numerical data
  • Consumer Behavior
  • Estrogens / pharmacology
  • Estrogens / therapeutic use
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Male
  • Prostatic Hyperplasia / drug therapy
  • Prostatic Hyperplasia / physiopathology
  • Prostatic Hyperplasia / surgery*
  • Urethra / surgery

Substances

  • Androgen Antagonists
  • Estrogens
  • Gonadotropin-Releasing Hormone